Overinhibition of corticostriatal activity following prenatal cocaine exposure

Annals of Neurology

Volumn 73, Issue 3, 2013, Pages 355-369

  Wang, Wengang ^a   Nitulescu, Ioana ^a   Lewis, Justin S ^a   Lemos, Julia C ^a,b   Bamford, Ian J ^a   Posielski, Natasza M ^a   Storey, Granville P ^a   Phillips, Paul E M ^a,b   Bamford, Nigel S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; AMPHETAMINE; COCAINE; DOPAMINE; GLUTAMIC ACID;

ABNORMAL BEHAVIOR; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; ELECTROPHYSIOLOGY; EXCITATION; FEMALE; HYPERPOLARIZATION; INHIBITION (PSYCHOLOGY); INTERNEURON; LOCOMOTION; MOUSE; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; STRESS; SYNAPTOSOME;

AGE FACTORS; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; BIOPHYSICS; CEREBRAL CORTEX; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; ELECTRIC STIMULATION; EMBRYO, MAMMALIAN; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; EXPLORATORY BEHAVIOR; FEMALE; GABA AGENTS; GREEN FLUORESCENT PROTEINS; HINDLIMB SUSPENSION; INTERNEURONS; LIDOCAINE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEURONAL PLASTICITY; PATCH-CLAMP TECHNIQUES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; QUINOXALINES; QUINPIROLE; RECEPTORS, GABA-A; ROTAROD PERFORMANCE TEST; SODIUM CHANNEL BLOCKERS; STATISTICS, NONPARAMETRIC; TETRODOTOXIN;

EID: 84876470224     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23805     Document Type: Article

References (49)

1. Church MW, Crossland WJ, Holmes PA, et al. Effects of prenatal cocaine on hearing, vision, growth, and behavior. Ann N Y Acad Sci 1998; 846: 12-28.
2. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. Updated on December 30, 2008. Available at: http://www.oas.samhsa.gov/nhsda.htm. Accessed September, 2012
3. Downs T, Padbury J, Blount L, et al. Ovine fetal-placental cocaine pharmacokinetics during continuous cocaine infusion. J Soc Gynecol Investig 1996; 3: 185-190.
4. Chiriboga CA, Bateman DA, Brust JC, Hauser WA,. Neurologic findings in neonates with intrauterine cocaine exposure. Pediatr Neurol 1993; 9: 115-119.
5. Bada HS, Das A, Bauer CR, et al. Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics 2007; 119: e348-e359.
6. Bandstra ES, Morrow CE, Mansoor E, Accornero VH,. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis 2010; 29: 245-258.
7. Ren JQ, Malanga CJ, Tabit E, Kosofsky BE,. Neuropathological consequences of prenatal cocaine exposure in the mouse. Int J Dev Neurosci 2004; 22: 309-320.
8. Byrnes JJ, Pritchard GA, Koff JM, Miller LG,. Prenatal cocaine exposure: decreased sensitization to cocaine and decreased striatal dopamine transporter binding in offspring. Neuropharmacology 1993; 32: 721-723.
9. Church MW, Tilak JP,. Differential effects of prenatal cocaine and retinoic acid on activity level throughout day and night. Pharmacol Biochem Behav 1996; 55: 595-605.
10. Keller RW Jr, Maisonneuve IM, Nuccio DM, et al. Effects of prenatal cocaine exposure on the nigrostriatal dopamine system: an in vivo microdialysis study in the rat. Brain Res 1994; 634: 266-274.
11. Albin RL, Young AB, Penney JB,. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-375.
12. Bamford NS, Cepeda C,. The corticostriatal pathway in parkinson's disease. In:, Tseng KY, ed. Cortico-subcortical dynamics in Parkinson's disease. New York, NY: Humana Press, 2009: 87-104.
13. Gerfen CR,. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 1992; 15: 285-320.
14. Koos T, Tepper JM,. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 1999; 2: 467-472.
15. Bamford NS, Zhang H, Schmitz Y, et al. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 2004; 42: 653-663.
16. Bamford NS, Robinson S, Palmiter RD, et al. Dopamine modulates release from corticostriatal terminals. J Neurosci 2004; 24: 9541-9552.
17. Saade NE, Atweh SF, Bahuth NB, Jabbur SJ,. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res 1997; 751: 1-12.
18. Hnasko TS, Sotak BN, Palmiter RD,. Morphine reward in dopamine-deficient mice. Nature 2005; 438: 854-857.
19. Perez FA, Palmiter RD,. Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci U S A 2005; 102: 2174-2179.
20. Bamford NS, Zhang H, Joyce JA, et al. Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron 2008; 58: 89-103.
21. Mori A, Ohashi S, Nakai M, et al. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Neurosci Res 2005; 51: 265-274.
22. Joshi PR, Wu NP, Andre VM, et al. Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. J Neurosci 2009; 29: 2414-2427.
23. Lu H, Lim B, Poo MM,. Cocaine exposure in utero alters synaptic plasticity in the medial prefrontal cortex of postnatal rats. J Neurosci 2009; 29: 12664-12674.
24. Phillips PE, Johns JM, Lubin DA, et al. Presynaptic dopaminergic function is largely unaltered in mesolimbic and mesostriatal terminals of adult rats that were prenatally exposed to cocaine. Brain Res 2003; 961: 63-72.
25. Simansky KJ, Kachelries WJ,. Prenatal exposure to cocaine selectively disrupts motor responding to D-amphetamine in young and mature rabbits. Neuropharmacology 1996; 35: 71-78.
26. Cryan JF, O'Leary OF, Jin SH, et al. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci U S A 2004; 101: 8186-8191.
27. Beutler LR, Wanat MJ, Quintana A, et al. Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization. Proc Natl Acad Sci U S A 2011; 108: 4206-4211.
28. Mennerick S, Zorumski CF,. Paired-pulse modulation of fast excitatory synaptic currents in microcultures of rat hippocampal neurons. J Physiol 1995; 488 (pt 1): 85-101.
29. Nisenbaum ES, Berger TW, Grace AA,. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors. Synapse 1993; 14: 221-242.
30. Wang W, Dever D, Lowe J, et al. Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core. J Physiol 2012; 590 (pt 16): 3743-3769.
31. Charara A, Heilman TC, Levey AI, Smith Y,. Pre- and postsynaptic localization of GABA(B) receptors in the basal ganglia in monkeys. Neuroscience 2000; 95: 127-140.
32. Centonze D, Grande C, Usiello A, et al. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci 2003; 23: 6245-6254.
33. Ibanez-Sandoval O, Tecuapetla F, Unal B, et al. Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum. J Neurosci 2010; 30: 6999-7016.
34. Bracci E, Centonze D, Bernardi G, Calabresi P,. Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol 2002; 87: 2190-2194.
35. Janssen MJ, Ade KK, Fu Z, Vicini S,. Dopamine modulation of GABA tonic conductance in striatal output neurons. J Neurosci 2009; 29: 5116-5126.
36. Marin O, Anderson SA, Rubenstein JL,. Origin and molecular specification of striatal interneurons. J Neurosci 2000; 20: 6063-6076.
37. Tepper JM, Wilson CJ, Koos T,. Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons. Brain Res Rev 2008; 58: 272-281.
38. Crandall JE, Hackett HE, Tobet SA, et al. Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex 2004; 14: 665-675.
39. Semyanov A, Walker MC, Kullmann DM, Silver RA,. Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 2004; 27: 262-269.
40. Wu Y, Wang W, Richerson GB,. The transmembrane sodium gradient influences ambient GABA concentration by altering the equilibrium of GABA transporters. J Neurophysiol 2006; 96: 2425-2436.
41. Tepper JM,. GABAergic interneurons of the striatum. In:, Steiner H, Tseng KY, eds. Handbook of basal ganglia structure and function. San Diego, CA: Elsevier, 2010: 151-166.
42. Friedman E, Wang HY,. Prenatal cocaine exposure alters signal transduction in the brain D1 dopamine receptor system. Ann N Y Acad Sci 1998; 846: 238-247.
43. Kim DS, Froelick GJ, Palmiter RD,. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J Neurosci 2002; 22: 9841-9849.
44. Kalivas PW, Volkow ND,. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162: 1403-1413.
45. Bosse R, Fumagalli F, Jaber M, et al. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 1997; 19: 127-138.
46. Fernandez F, Garner CC,. Over-inhibition: a model for developmental intellectual disability. Trends Neurosci 2007; 30: 497-503.
47. Purves D, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 4th ed., Purves D, ed. Sunderland, MA: Sinauer Associates, 2008.
48. Arias Montano JA, Martinez-Fong D, Aceves J,. GABAB receptor activation partially inhibits N-methyl-D-aspartate-mediated tyrosine hydroxylase stimulation in rat striatal slices. Eur J Pharmacol 1992; 218: 335-338.
49. Kawaguchi Y,. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci 1993; 13: 4908-4923.